Infectious complications of lung transplantation: Impact of cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 149, Issue 6, 1994, Pages 1601-1607

  Flume, Patrick A ^a   Egan, Thomas M ^b   Paradowski, Linda J ^b   Detterbeck, Frank C ^b   Thompson, Jeanette T ^b   Yankaskas, James R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; NYSTATIN; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLUS; BACTERIAL COLONIZATION; BRONCHIOLITIS; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; FEMALE; GRAFT INFECTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0028308215     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.149.6.7516251     Document Type: Article

References (32)

1. Frist WH, Fox MD, Campbell PW, Fiel SB, Loyd JE, Merrill WH. Cystic fibrosis treated with heart-lung transplantation: North American results. Transplant Proc 1991;23:1205-6.
2. de Levai MR, Smyth R, Whitehead B, Scott JP, Elliot MJ, Sharpies L, Caine N, Helms P, Martin IR, Higenbottam T, Wallwork J. Heart and lung transplantation for terminal cystic fibrosis. J Thorac Cardiovasc Surg 1991;101:633-42.
3. Ramirez JC, Patterson GA, Winton TL, de Hoyos AL, Miller JD, Maurer JR. Bilateral lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1992;103:287-94.
4. Shenib H, Noirclerc M, Ernst P, Metras D, Mulder DS, Giudicelli R, Lebel F, Duman J. Double-lung transplantation for cystic fibrosis. Ann Thorac Surg 1992;54:27-32.
5. Wood A, Higenbottam T, Jackson M, Scott J, Stewart S, Wallwork J. Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis 1989;140:1645-9.
6. Marshall SE, Kramer MR, Lewiston NJ, Starnes VA, Theodore J. Selection and evaluation of recipients for heart-lung and lung transplantation. Chest 1990;98:488-94.
7. Lewin LO, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990;43:125-31.
8. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplantation recipients with cystic fibrosis. Chest 1993;103:466-71.
9. Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Ann Surg 1983; 198:622-9.
10. Egan TM, Kaiser LR, Cooper JD. Lung transplantation. Curr Probl Surg 1989;26:675-751.
11. Egan TM. Selection and management of the lung donor. In: Kaye MP, O'Connell J, eds. Intrathoracic transplantation 2000. Austin: R.G. Landes, 1993;25-30.
12. Egan TM, Detterbeck FC. Technique and results of double lung transplantation. Chest Surg Clin 1993;3:89-111.
13. Egan TM, Cooper JD. Surgical aspects of single lung transplantation. Clin Chest Med 1990;11:195-205.
14. Back DJ, Tjia JF. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol 1991; 32:624-6.
15. Ah-Sing E, Poole TW, Ioannides C, King LJ. Mechanism of the ketoconazole-cyclosporin interaction. Arch Toxicol 1990;64:511-3.
16. Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A, Yacoub MY. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet 1992;339:1583-7.
17. Scott J, Higenbottam T, Mutter J, Hodson M, Stewart S, Penket A, Wallwork J. Heart-lung transplantation for cystic fibrosis. Lancet 1988;ii:192-4.
18. Caine N, Sharples LD, Smyth R, Scott J, Higenbottam TW, Wallwork J. Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc 1991;23:1203-4.
19. Waltner WE, Boucher RC, Gatzy JT, Knowles MR. Pharmacotherapy of airway disease in cystic fibrosis. Trends Pharmacol Sci 1987;8:316-20.
20. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
21. Olivier KN, Gilligan P, Yankaskas JR, Knowles MR. Pulmonary nontuberculous mycobacteria in cystic fibrosis. Pediatr Pulmonol 1992; 8(Suppl: 116-7).
22. Egan TM. Lung transplantation in cystic fibrosis. Semin Respir Infect 1992;7:227-39.
23. Sun L, Jiang RZ, Steinbach S, Gilligan P, Forstner J, Flume P, Goldstein R. Epidemiology of P. cepacia infection at the molecular genetic level, (ii) Evidence for variable transmissibility. Pediatr Pulmonol 1993;9(Suppl:260-1).
24. Cahill BC, Juni BA, Savik SK, Dosland BM, Edin CL, Rhame FS, Hertz MI. The significance of aspergillus in the lung transplant recipient: frequent isolates, infrequent disease (abstract). Am Rev Respir Dis 1993;147:A601.
25. Tsang V, Hodson ME, Yacoub MH. Lung transplantation for cystic fibrosis. Br Med Bull 1992;48:949-71.
26. Westney G, Maurer JR, de Hoyos A, Chaparro C, Winton T, Kesten S. Aspergillus infections in lung transplant recipients (abstract). Am Rev Respir Dis 1993;147:A600.
27. Ladurie FL, Cerrina J, Parquin F, Hervé P. Description and treatment of an outbreak of Aspergillus bronchitis in lung transplant recipients (abstract). Am Rev Respir Dis 1993;147:A600.
28. Denning DW, Stevens DA. The treatment of invasive aspergillosis: surgery and antifungal therapy of 2,121 published cases. Rev Infect Dis 1990;12:1147-201.
29. Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21.
30. Lewiston N, King V, Umetsu D, Starnes V, Marshall S, Kramer M, Theodore J. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991;23:1207-8.
31. Umetsu DT, Moss RB, King VV, Lewiston NJ. Sinus disease in patients with severe cystic fibrosis and relation to pulmonary exacerbation. Lancet 1990;335:1077-8.
32. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990;11:291-308.